Akoya Financial Statements From 2010 to 2025

AKYA Stock  USD 1.56  0.06  4.00%   
Akoya Biosciences financial statements provide useful quarterly and yearly information to potential Akoya Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Akoya Biosciences financial statements helps investors assess Akoya Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Akoya Biosciences' valuation are summarized below:
Akoya Biosciences does not presently have any fundamental signals for analysis.
Check Akoya Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Akoya Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Akoya financial statements analysis is a perfect complement when working with Akoya Biosciences Valuation or Volatility modules.
  
Check out the analysis of Akoya Biosciences Correlation against competitors.
For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.

Akoya Biosciences Company Current Valuation Analysis

Akoya Biosciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Akoya Biosciences Current Valuation

    
  123.88 M  
Most of Akoya Biosciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akoya Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Akoya Biosciences has a Current Valuation of 123.88 M. This is 99.14% lower than that of the Health Care Equipment & Supplies sector and 98.65% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.25% higher than that of the company.

Akoya Biosciences Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Akoya Biosciences's current stock value. Our valuation model uses many indicators to compare Akoya Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Akoya Biosciences competition to find correlations between indicators driving Akoya Biosciences's intrinsic value. More Info.
Akoya Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Akoya Biosciences' earnings, one of the primary drivers of an investment's value.

About Akoya Biosciences Financial Statements

Akoya Biosciences stakeholders use historical fundamental indicators, such as Akoya Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Akoya Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Akoya Biosciences' assets and liabilities are reflected in the revenues and expenses on Akoya Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Akoya Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts. Akoya Biosciences operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 319 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Akoya Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akoya Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akoya Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akoya Biosciences Stock:
Check out the analysis of Akoya Biosciences Correlation against competitors.
For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akoya Biosciences. If investors know Akoya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akoya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Akoya Biosciences is measured differently than its book value, which is the value of Akoya that is recorded on the company's balance sheet. Investors also form their own opinion of Akoya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Akoya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akoya Biosciences' market value can be influenced by many factors that don't directly affect Akoya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akoya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akoya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akoya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.